CONFERENCES
ISRAEL NEWS
HEALTH & WELLNESS
WORLD NEWS
MIDDLE EAST
BUSINESS & INNOVATION
OPINION
JP STORE
Login
Login
Subscribe
JPOST DIGITAL LIBRARY
HOME PAGE
BUSINESS & INNOVATION
OPINION
REAL ESTATE LISTINGS
ALIYAH
JERUSALEM POST CONFERENCE
PREMIUM
JP STORE
Categories
ISRAEL NEWS
WORLD NEWS
MIDDLE EAST
ARAB ISRAELI CONFLICT
US POLITICS
DIASPORA
OPINION
PODCAST
JUDAISM
KABBALAH
CHRISTIAN WORLD
HEALTH & WELLNESS
SCIENCE
LAW
ARCHAEOLOGY
OMG
ENVIRONMENT & CLIMATE CHANGE
FOOD & RECIPES
JERUSALEM POST EN ESPANOL
HISTORY
SPONSORED CONTENT
ADVERTISE WITH US
TERMS OF USE
PRIVACY POLICY
CONTACT US
CANCEL SUBSCRIPTION
CUSTOMER SERVICE
ABOUT US
Jerusalem Post
/
Health & Wellness
86-year-old Copaxone creator has no intention of slowing down
When it comes to being excited by experiments, age is simply not a factor for 86-year-old Prof. Ruth Arnon, co-creator of multiple sclerosis drug Copaxone.
Professor Ruth Arnon, who was awarded the 2020 OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit at the OurCrowd Global Investor Summit. February 13, 2020.
(photo credit:
MARC ISRAEL SELLEM
)
By
EYTAN HALON
FEBRUARY 13, 2020 22:15
See more on
Pharmaceuticals
|
Multiple Sclerosis
RECOMMENDED STORIES
Iranian official claims Israel used 'the occult and supernatural spirits' during 12-day war
JULY 13, 2025
Israel and US plan joint $200 million quantum fund, eyeing collaboration with UAE and Saudi Arabia
JULY 13, 2025
IDF strikes Syrian tanks that advanced towards sectarian violence, near Israel's border
JULY 14, 2025
Asteroid the size of 145 Elmos to fly past Earth on Tuesday, July 15 - NASA
JULY 14, 2025
Hot Opinion
Israel's strike on Syria: Defending the Druze and standing up for justice
By
JPOST EDITORIAL
WATCH: Jews on Dagestan flight hidden away from antisemitic mob - exclusive
By
ZVIKA KLEIN
Israeli-Syrian security arrangement: A new model of normalization?
By
ELIE PODEH
Middle East's post-Iran era has begun, no matter how hard Islamic regime denies it
By
SALEM ALKETBI